Insights

More Articles Back to Article

FDA grants Inovio clearance for COVID-19 vaccine trial

Inovio Pharmaceuticals has received FDA clearance to launch its midstage trial to test its COVID-19 vaccine candidate INO-4800. The midstage portion of the trial will involve 400 participants across 17 clinical sites throughout the US. The Business Journals (tiered subscription model) (11/16)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!